Processa Pharmaceuticals, Inc. Amortization
Processa Pharmaceuticals, Inc. (PCSA) reported Amortization of $446.43 thousand for the 33-month period ending 2013-12-31, per its 10-K filed 2014-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2014-03-27
- Processa Pharmaceuticals, Inc. amortization for the quarter ending 2013-12-31 was $89.29K.
- Processa Pharmaceuticals, Inc. amortization for the quarter ending 2013-09-30 was $89.29K.
- Processa Pharmaceuticals, Inc. amortization for fiscal 2013 was $357.14K, a 300.00% increase from fiscal 2012.
- Processa Pharmaceuticals, Inc. amortization for fiscal 2012 was $89.28K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 27 month | Amortization 30 month | Amortization 33 month |
|---|---|---|---|---|---|---|---|
| 2013-12-31 | $89.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $178.57K derived: sum of 2 quarters · filed 2014-03-27 | $357.14K 10-K · filed 2014-03-27 | $446.43K 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $89.29K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $267.86K 10-Q · filed 2013-11-08 | $357.14K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $178.57K 10-Q/A · filed 2013-09-06 | $267.86K 10-Q/A · filed 2013-09-06 | |||||
| 2012-12-31 | $89.28K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |